118 related articles for article (PubMed ID: 20974667)
1. Covariate-adjusted response-adaptive designs for longitudinal treatment responses: PEMF trial revisited.
Biswas A; Park E; Bhattacharya R
Stat Methods Med Res; 2012 Aug; 21(4):379-92. PubMed ID: 20974667
[TBL] [Abstract][Full Text] [Related]
2. Covariate-adjusted adaptive designs for continuous responses in a phase III clinical trial: recommendation for practice.
Biswas A; Huang HH; Huang WT
J Biopharm Stat; 2006; 16(2):227-39. PubMed ID: 16584069
[TBL] [Abstract][Full Text] [Related]
3. Optimal response-adaptive designs for continuous responses in phase III trials.
Biswas A; Bhattachary R; Zhang L
Biom J; 2007 Dec; 49(6):928-40. PubMed ID: 17722195
[TBL] [Abstract][Full Text] [Related]
4. An urn model for odds-ratio-based response-adaptive phase III clinical trials for two or more treatments.
Basak GK; Biswas A; Volkov S
J Biopharm Stat; 2009 Sep; 19(5):838-56. PubMed ID: 20183447
[TBL] [Abstract][Full Text] [Related]
5. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
6. Covariate-adjusted response-adaptive designs for binary response.
Rosenberger WF; Vidyashankar AN; Agarwal DK
J Biopharm Stat; 2001 Nov; 11(4):227-36. PubMed ID: 12018777
[TBL] [Abstract][Full Text] [Related]
7. Sequential urn designs with elimination for comparing K > or =3 treatments.
Coad DS; Ivanova A
Stat Med; 2005 Jul; 24(13):1995-2009. PubMed ID: 15803441
[TBL] [Abstract][Full Text] [Related]
8. Frequentist performance of Bayesian inference with response-adaptive designs.
Lecoutre B; Derzko G; Elqasyr K
Stat Med; 2010 Dec; 29(30):3219-31. PubMed ID: 21170916
[TBL] [Abstract][Full Text] [Related]
9. Optimal response-adaptive designs for normal responses.
Biswas A; Bhattacharya R
Biom J; 2009 Feb; 51(1):193-202. PubMed ID: 19197961
[TBL] [Abstract][Full Text] [Related]
10. An urn based covariate adjusted response adaptive allocation design.
Bandyopadhyay U; Bhattacharya R
Stat Methods Med Res; 2012 Apr; 21(2):135-48. PubMed ID: 22287603
[TBL] [Abstract][Full Text] [Related]
11. A covariate adjusted two-stage allocation design for binary responses in randomized clinical trials.
Bandyopadhyay U; Biswas A; Bhattacharya R
Stat Med; 2007 Oct; 26(24):4386-99. PubMed ID: 17348082
[TBL] [Abstract][Full Text] [Related]
12. Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses.
Atkinson AC; Biswas A
Stat Med; 2005 Aug; 24(16):2477-92. PubMed ID: 16007571
[TBL] [Abstract][Full Text] [Related]
13. Multiple-objective response-adaptive repeated measurement designs in clinical trials for binary responses.
Liang Y; Li Y; Wang J; Carriere KC
Stat Med; 2014 Feb; 33(4):607-17. PubMed ID: 24038318
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
Localio AR; Berlin JA; Have TR
Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
[TBL] [Abstract][Full Text] [Related]
15. Block response-adaptive randomization in clinical trials with binary endpoints.
Magirr D
Pharm Stat; 2011; 10(4):341-6. PubMed ID: 22328326
[TBL] [Abstract][Full Text] [Related]
16. The use of the triangular test with response-adaptive treatment allocation.
Coad DS; Ivanova A
Stat Med; 2005 May; 24(10):1483-93. PubMed ID: 15706635
[TBL] [Abstract][Full Text] [Related]
17. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
Atkinson AC; Biswas A
Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
[TBL] [Abstract][Full Text] [Related]
18. A class of Covariate-Adjusted Response-Adaptive Allocation Designs for Multitreatment Binary Response Trials.
Biswas A; Bhattacharya R
J Biopharm Stat; 2018; 28(5):809-823. PubMed ID: 29913107
[TBL] [Abstract][Full Text] [Related]
19. Balancing statistical and ethical considerations in planning clinical trials: recommendations for response-adaptive randomization urn designs.
Piccorelli AV; Fraker SA
J Biopharm Stat; 2018; 28(6):1105-1118. PubMed ID: 29442610
[TBL] [Abstract][Full Text] [Related]
20. Power and sample size simulations for Randomized Play-the-Winner rules.
Guimaraes P; Palesch Y
Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
